Business Unit Director TECA & Sports

About the role

Johnson & Johnson is looking for a Business Unit Director for its TECA (Trauma, Extremities, Animal Health & Craniomaxillofacial) and Sportsmed/Shoulder business, based in Zuchwil, Switzerland. The role carries end-to-end accountability for strategy, growth, profitability, asset efficiency and commercial execution, and leads the commercial and marketing teams. It combines strong strategic leadership with hands-on operational execution.

Key responsibilities

• Own full P&L responsibility for the TECA & Sportsmed/Shoulder business in Switzerland, ensuring sustainable and profitable growth.
• Define and execute national strategy, integrating digital solutions and technologies as a core differentiator.
• Lead national commercial and marketing organizations, driving execution, customer engagement and talent development.
• Drive disciplined asset efficiency, including capital investment prioritization, utilization, lifecycle management and return on capital.
• Partner with Finance on budgeting, forecasting, financial planning and performance management.
• Work with Operations and Supply Chain to ensure operational robustness, service excellence and scalability.
• Act as the primary national business leader for clinical, economic and executive stakeholders, and serve as an interface with regional and global teams.
• Build and lead a high-performing leadership team with a results-driven, compliant and engaged culture.

Required profile

• Minimum of 10 years of experience leading orthopedic businesses, with strong preference for joint reconstruction leadership at national level.
• Demonstrated track record of full P&L ownership and profitable growth.
• Solid experience managing large, complex, cross-functional organizations.
• High credibility with senior clinical, economic and executive stakeholders.
• Fluency in German and English.
• Experience in a well-established TECA & Sportsmed/Shoulder company is strongly preferred.

The posting notes that Johnson & Johnson announced plans to separate its Orthopedics business into a standalone company, DePuy Synthes, expected to be completed within 18 to 24 months; after the transaction, the role would fall under the new company's employment processes.